Optimized clinical-scale culture conditions for ex vivo selective depletion of host-reactive donor lymphocytes: a strategy for GvHD prophylaxis in allogeneic PBSC transplantation

By Solomon SR   Tran T   Carter CS   Donnelly S   Hensel N   Schindler J   Bahceci E   Ghetie V   Michálek J   Mavroudis D   Read EJ   Vitetta ES   Barrett AJ  

Cytotherapy, Vol. 4, Iss. 5, 2002-09 ,pp. : 395-406

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Improving the ex vivo retroviral-mediated suicide-gene transfer process in T lymphocytes to preserve immune function

By Robinet E   Fehse B   Ebeling S   Sauce D   Ferrand C   Tiberghien P  

Cytotherapy, Vol. 7, Iss. 2, 2005-05 ,pp. : 150-157

Ashgate Publishing Ltd

Access to resources Recommend Favorite

An analysis of the effect of chronic GvHD on relapse and survival following allogeneic PBSC transplantation

By Miflin G.   Russell N.   Franklin I.   Cook G.   Milligan D.W.   Hutchinson R.M.   Potter M.N.   Morgan G.J.   Pagliuca A.   Marsh J.   Bell A.  

Cytotherapy, Vol. 2, Iss. 6, 2000-06 ,pp. : 423-428

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Improving immune reconstitution while preventing GvHD in allogeneic stem cell transplantation

By André-Schmutz I   Cortivo L Dal   Fischer A   Cavazzana-Calvo M  

Cytotherapy, Vol. 7, Iss. 2, 2005-05 ,pp. : 102-108

Ashgate Publishing Ltd

Access to resources Recommend Favorite

In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantation

By Kottaridis PD   Milligan DW   Chopra R   Chakraverty RK   Chakrabarti S   Robinson S   Peggs K   Verfuerth S   Pettengell R   Marsh JCW   Schey S   Mahendra P   Morgan GJ   Hale G   Waldmann H   De Elvira MC   Williams CD   Devereux S   Linch DC   Goldstone AH   MacKinnon S  

Cytotherapy, Vol. 3, Iss. 3, 2001-05 ,pp. : 197-201

Ashgate Publishing Ltd

Access to resources Recommend Favorite